Adding Naltrexone to the Achieving Better Care by Monitoring All Prescriptions Program (ABC-MAP) Act.
July 7, 2017 04:39 PM to All House Members
Circulated By
Representative Mark Rozzi
D House District 126
Memo
In the near future, I plan to introduce legislation to include naltrexone, which is used to treat opioid disorders and alcohol use, in the Achieving Better Care by Monitoring All Prescriptions Program (ABC-MAP) Act of 2014 (P.L.2911, No.191).
This proposal will add naltrexone to the definition of controlled substance under the act. While I understand that naltrexone is not a controlled substance, it is imperative that naltrexone is captured under the act as its combined use with opioids may be life-threatening.
The Substance Abuse and Mental Health Services Administration explains that if patients who are treated with naltrexone relapse after a period of abstinence, it is possible that the dosage of opioid that was previously used may result in respiratory arrest and circulatory collapse.
After meeting with specialists in my district, I feel that the inclusion of naltrexone in ABC-MAP is necessary in assessing a patient's situation. Therefore, in an effort to protect patients, I urge your support and co-sponsorship.
This proposal will add naltrexone to the definition of controlled substance under the act. While I understand that naltrexone is not a controlled substance, it is imperative that naltrexone is captured under the act as its combined use with opioids may be life-threatening.
The Substance Abuse and Mental Health Services Administration explains that if patients who are treated with naltrexone relapse after a period of abstinence, it is possible that the dosage of opioid that was previously used may result in respiratory arrest and circulatory collapse.
After meeting with specialists in my district, I feel that the inclusion of naltrexone in ABC-MAP is necessary in assessing a patient's situation. Therefore, in an effort to protect patients, I urge your support and co-sponsorship.
Legislation
Document - Introduced as HB 2047
Adding Naltrexone to the Achieving Better Care by Monitoring All Prescriptions Program (ABC-MAP) Act.
July 7, 2017 04:39 PM to All House Members
Circulated By
ROZZI
Memo
In the near future, I plan to introduce legislation to include naltrexone, which is used to treat opioid disorders and alcohol use, in the Achieving Better Care by Monitoring All Prescriptions Program (ABC-MAP) Act of 2014 (P.L.2911, No.191).
This proposal will add naltrexone to the definition of controlled substance under the act. While I understand that naltrexone is not a controlled substance, it is imperative that naltrexone is captured under the act as its combined use with opioids may be life-threatening.
The Substance Abuse and Mental Health Services Administration explains that if patients who are treated with naltrexone relapse after a period of abstinence, it is possible that the dosage of opioid that was previously used may result in respiratory arrest and circulatory collapse.
After meeting with specialists in my district, I feel that the inclusion of naltrexone in ABC-MAP is necessary in assessing a patient's situation. Therefore, in an effort to protect patients, I urge your support and co-sponsorship.
This proposal will add naltrexone to the definition of controlled substance under the act. While I understand that naltrexone is not a controlled substance, it is imperative that naltrexone is captured under the act as its combined use with opioids may be life-threatening.
The Substance Abuse and Mental Health Services Administration explains that if patients who are treated with naltrexone relapse after a period of abstinence, it is possible that the dosage of opioid that was previously used may result in respiratory arrest and circulatory collapse.
After meeting with specialists in my district, I feel that the inclusion of naltrexone in ABC-MAP is necessary in assessing a patient's situation. Therefore, in an effort to protect patients, I urge your support and co-sponsorship.
Document
Introduced as HB 2047
Generated 03/23/2025 09:17 PM